Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus. (ORIGAMI)

This study has been terminated.
(Potential hepatic safety signal)
Sponsor:
Information provided by (Responsible Party):
Takeda
ClinicalTrials.gov Identifier:
NCT00759720
First received: September 24, 2008
Last updated: February 1, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2004
  Primary Completion Date: December 2004 (Final data collection date for primary outcome measure)